Clinical Edge Journal Scan

Higher vitamin B6 and folate intake tied to lower severe headache or migraine risk


 

Key clinical point: Higher dietary intakes of vitamin B 6 and folate were significantly associated with a lower risk for severe headaches or migraines, with a synergistic interaction observed between vitamin B 6 and folate intake and reduced migraine risk.

Major finding: Compared with the lowest quintile of dietary vitamin B 6 (≤1.13 mg/day) and folate (≤240 μg/day) intake, the risk for severe headache or migraine was lower in the highest quintile of vitamin B 6 (≥2.39 mg/day; adjusted odds ratio [aOR] 0.66; P = .01) and folate (≥502.01 μg/day; aOR 0.57; P = .002) intake. A synergistic interaction was observed between the high mass of vitamin B 6 and folate intake and a lower risk for severe headache or migraine (synergy index 0.58; 95% CI 0.40-0.83).

Study details: This cross-sectional study included 7017 adult participants (age ≥ 20 years), of whom 1350 (19.23%) had migraine.

Disclosures: This study was supported by the National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, and others. No conflicts of interests were declared.

Source: Tian S et al. Vitamin B 6 and folate intake are associated with lower risk of severe headache or migraine in adults: An analysis based on NHANES 1999-2004. Nutr Res. 2023;121:51-60 (Nov 15). doi: 10.1016/j.nutres.2023.11.008

Recommended Reading

Considering high-dose EPA/DHA as a primary option for migraine prevention
Migraine ICYMI
Gut microbiota and migraine: Is there a link?
Migraine ICYMI
Agomelatine offers an effective preventive treatment for episodic migraine without aura
Migraine ICYMI
Genetic factors influence response to anti-CGRP antibodies in migraine
Migraine ICYMI
Erenumab demonstrates more favorable efficacy than rimegepant for migraine prevention
Migraine ICYMI
Meta-analysis shows comorbid association between migraine and epilepsy
Migraine ICYMI
Patients with migraine face an elevated risk for Parkinson's disease
Migraine ICYMI
Higher delayed discounting rate among patients with episodic migraine without aura
Migraine ICYMI
Real-world comparison of treatment pattern of CGRP antibodies in migraine
Migraine ICYMI
Commentary: Gut Microbiota and CGRP in Migraine, February 2024
Migraine ICYMI